Schedule I - Condensed Financial Information of the Registrant - Condensed Statements of Cash Flows (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Net loss	$ (11,521)	$ (20,846)	$ (45,106)
Amortization of deferred loan costs and discount	91,474	77,535	71,649
Payment-in-kind interest payments		(37,624)	(2,698)
Payment-in-kind interest capitalized			15,935
Write off of Deferred Debt Issuance Cost		3,876	3,294
Prepaid expenses	715	(895)	(599)
Accounts payable and accrued liabilities	(6,827)	(6,063)	8,451
Net cash provided by (used in) operating activities	87,989	45,511	44,008
Net cash (used in) provided by investing activities	(127,932)	(70,114)	(120,811)
Repayment of seller notes			(12,401)
Repayment of senior secured credit facilities		(115,000)	(410,655)
Proceeds from employees in advance of common stock issuance			25
Repurchase of shares	(1,320)
Proceeds from issuance of common stock		176,341
Proceeds from stock option exercise	685	774
Net cash (used in) provided by financing activities	(17,683)	76,066	78,054
(Decrease) increase in cash and cash equivalents	(57,622)	51,462	1,265
Cash, cash equivalents and restricted cash, beginning of period	70,804	19,342	18,077
Cash, cash equivalents and restricted cash, end of period	13,182	70,804	19,342
Parent Company [Member]
Net loss	(11,752)	(20,846)	(45,106)
Amortization of deferred loan costs and discount			479
Payment-in-kind interest payments		(37,624)	(1,108)
Payment-in-kind interest capitalized			15,933
Write off of Deferred Debt Issuance Cost		3,037
Prepaid expenses	23	5	(14)
Intercompany payable/receivable	570	365	306
Accounts payable and accrued liabilities			(36)
Net cash provided by (used in) operating activities	648	(38,667)	(1,244)
Investment in subsidiaries	(13,280)	(12,100)	(7,965)
Distributions received from subsidiaries			8,084
Net cash (used in) provided by investing activities	(13,280)	(12,100)	119
Repayment of seller notes			(6,870)
Repayment of senior secured credit facilities		(115,000)
Proceeds from employees in advance of common stock issuance			25
Repurchase of shares	(1,320)
Proceeds from issuance of common stock		176,341
Proceeds from stock option exercise	685	774
Net cash (used in) provided by financing activities	(635)	62,115	(6,845)
(Decrease) increase in cash and cash equivalents	(13,267)	11,348	(7,970)
Cash, cash equivalents and restricted cash, beginning of period	13,549	2,201	10,171
Cash, cash equivalents and restricted cash, end of period	$ 282	$ 13,549	$ 2,201